Evidence map›Paper›PMID 42602649›Full record

ArticleACS polymers Au2026

Dynamic Arrest and Tunable Gelation of Immunogenically Inert POEGMA Nanoparticles.

Parul Sirohi, Max R Ney, Yulia Shmidov, Brooke E Silverstein, Anurag Singh, Gable Wadsworth, Sonal Deshpande, Yvonne Y Ma, Lixin Fan, Priya R Banerjee and 1 more

Abstract read
In one paragraph

Article in ACS polymers Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Parul SirohiDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID https://orcid.org/0000-0002-5791-3383
Max R NeyDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Yulia ShmidovDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID https://orcid.org/0000-0003-4152-0670
Brooke E SilversteinDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Anurag SinghDepartment of Physics, University at Buffalo, SUNY, Buffalo, New York 14260, United States.
Gable WadsworthDepartment of Physics, University at Buffalo, SUNY, Buffalo, New York 14260, United States.ORCID https://orcid.org/0000-0002-0417-9613
Sonal DeshpandeDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID https://orcid.org/0000-0003-3055-0065
Yvonne Y MaDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.
Lixin FanBasic Science Program, Frederick National Laboratory for Cancer Research, SAXS Facility of the National Cancer Institute, Frederick, Maryland 21702, United States.
Priya R BanerjeeDepartment of Physics, University at Buffalo, SUNY, Buffalo, New York 14260, United States.ORCID https://orcid.org/0000-0002-6169-1461
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.ORCID https://orcid.org/0000-0002-1569-2228

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Vivian Stojanoff · 2019 to 2026
$38.6M
Quantifying Physiologic and Pathologic Viscoelastic Phases of Biomolecular Condensates by Correlative Force and Fluorescence MicroscopyR35GM138186 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BANERJEE, PRIYA R. · 2020 to 2025
$4.4M
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes TreatmentR01DK124276 · NIDDK · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2021 to 2024
$1.9M
A Simultaneous SAXS/WAXS Detector System for Solving Biological StructuresS10OD012331 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI ALLAIRE, MARC · 2012 to 2012
$1.1M
NIDDK NIH HHS R01 DK124276NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R35 GM138186NIH HHS 75N91019D00024NIH HHS S10 OD012331
6 · The paper itself

Abstract

Physically cross-linked hydrogels formed through noncovalent interactions offer reversible gelation, injectability, and shear-thinning behavior, making them ideal for biomedical applications. Temperature-responsive systems are particularly attractive, as they enable injection as a solution, and at physiological temperature for minimally invasive delivery. Poly-(oligo-(ethylene glycol) methacrylate) (POEGMA) is a promising nonimmunogenic polymer that combines PEG-like hydration and protein resistance with tunable thermal responsiveness that does not bind pre-existing anti-PEG antibodies that are ubiquitous and elicits a minimal antibody response against itself. Here, we show that diblock POEGMA copolymerscomposed solely of short ethylene glycol side chainsspontaneously self-assemble into nanoparticles and form physically cross-linked hydrogels above a controllable transition temperature, without chemical modification. Using fluorescence recovery after photobleaching and video particle tracking nanorheology, we identify a thermally induced transition from dynamically arrested viscoelastic hydrogels to dynamically arrested liquid coacervates. These results establish a new class of single-component, nonimmunogenic POEGMA hydrogels with tunable phase behavior and mechanical properties, offering a versatile platform for localized drug delivery, sustained release, and regenerative medicine.

Indexed as

coacervatehydrogelLCSTnanoparticlesnanorheologyPOEGMAself-assembly

Identifiers

PMID42602649
PMCPMC13474346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.